Among patients with positive landmark MRD and positive longitudinal MRD, cfDNA_ KRAS+ showed a trend to poorer DFS (Figure 3A and B ).
← all excerpts
Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer.
1
—
—